Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 5/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

3 trials in Phase 3/4

Results Transparency

113%

9 of 8 completed trials have results

Key Signals

9 with results

Enrollment Performance

Analytics

N/A

6(66.7%)

Phase 4

3(33.3%)

9Total

N/A(6)

Phase 4(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT03610737Not ApplicableActive Not Recruiting

The MOTION Study - Treatment of LSS With the MILD Procedure

Role: lead

NCT02093520Not ApplicableCompleted

The MiDAS ENCORE Study

Role: lead

NCT01315145Not ApplicableCompleted

MiDAS III (Mild® Decompression Alternative to Open Surgery): Vertos Mild Patient Evaluation Study

Role: lead

NCT00995371Phase 4Completed

Study of Epidural Steroid Injection (ESI) Versus Minimally Invasive Lumbar Decompression (Mild®) in Patients With Symptomatic Lumbar Central Canal Stenosis

Role: collaborator

NCT01129921Not ApplicableCompleted

Comparative Study of Sham Versus Mild® Procedure in Patients Diagnosed With Symptomatic Lumbar Central Canal Stenosis

Role: collaborator

NCT00749073Not ApplicableCompleted

The Vertos MILD™ Preliminary Patient Evaluation Study

Role: lead

NCT00956631Phase 4Completed

MiDAS I (Mild® Decompression Alternative to Open Surgery): Vertos Mild Patient Evaluation Study

Role: lead

NCT01076244Not ApplicableCompleted

Vertos Mild - Post Market Patient Outcomes

Role: collaborator

NCT01082159Phase 4Completed

MiDAS II (Mild® Decompression Alternative to Open Surgery): Vertos Mild Patient Evaluation Study

Role: lead

All 9 trials loaded